MIT Sloan Says the Biggest AI Opportunity in Healthcare Is Not the Obvious One
MIT Sloan argues that the highest-value AI opportunities in healthcare may not be the consumer-facing or headline-grabbing ones. Instead, the real payoff could come from less visible areas where AI improves workflows, coordination, and decision-making.
Healthcare AI conversation often gravitates toward chatbots, patient-facing assistants, and futuristic diagnosis tools. MIT Sloan’s framing pushes in a different direction: the most durable gains may come from the parts of the system that are boring, fragmented, and expensive to run.
That perspective is important because healthcare rarely fails at the point of invention; it fails at the point of implementation. Tools that help with supply chains, staffing, documentation routing, prior authorizations, or operational forecasting may never generate the same buzz as a diagnostic model, but they can affect margins and patient access much more directly.
The article also reflects a maturing market. As systems become more cautious about clinical liability and more skeptical of vendor hype, buyers are increasingly looking for AI that fits into existing operational constraints. In practice, that means value is likely to accrue to tools that reduce friction in everyday work rather than those that promise to reinvent care overnight.
The broader implication is that healthcare AI may be entering a less glamorous but more consequential phase. If the industry wants real ROI, it may need to stop treating AI as a novelty and start treating it as infrastructure.